These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16719269)
1. [Treatment with the first glycylcycline--tigecycline]. Musch A Med Monatsschr Pharm; 2006 May; 29(5):191-2. PubMed ID: 16719269 [No Abstract] [Full Text] [Related]
2. What role for tigecycline in infections? BMJ Group Drug Ther Bull; 2008 Aug; 46(8):62-4. PubMed ID: 18687585 [TBL] [Abstract][Full Text] [Related]
3. [Bacterial resistance and a new antibiotic: tigecycline]. Gobernado M Rev Esp Quimioter; 2006 Sep; 19(3):209-19. PubMed ID: 17099789 [No Abstract] [Full Text] [Related]
5. Off-label use of antibiotics in hospitalized patients: focus on tigecycline. Curcio D J Antimicrob Chemother; 2009 Dec; 64(6):1344-6. PubMed ID: 19759045 [No Abstract] [Full Text] [Related]
6. A review of tigecycline--the first glycylcycline. Peterson LR Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S215-22. PubMed ID: 19134522 [TBL] [Abstract][Full Text] [Related]
7. Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes. Conde-Estévez D; Grau S; Horcajada JP; Luque S Int J Antimicrob Agents; 2010 Nov; 36(5):471-2. PubMed ID: 20828992 [No Abstract] [Full Text] [Related]
8. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines]. Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033 [No Abstract] [Full Text] [Related]
9. Effectiveness and safety of tigecycline: focus on use for approved indications. Vardakas KZ; Rafailidis PI; Falagas ME Clin Infect Dis; 2012 Jun; 54(11):1672-4. PubMed ID: 22431809 [No Abstract] [Full Text] [Related]
10. Tigecycline: benefits and risks. Cai Y; Wang R Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707 [No Abstract] [Full Text] [Related]
11. Economic impact simulation analysis of use of tigecycline, as appropriate, in first-course antibiotic therapy for complicated intra-abdominal infections in intensive care patients. Ancona F Minerva Med; 2010 Oct; 101(5):319-28. PubMed ID: 21048554 [TBL] [Abstract][Full Text] [Related]
12. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of tigecycline in the management of complicated skin and skin structure infections. Grolman DC Int J Infect Dis; 2007 May; 11 Suppl 1():S7-15. PubMed ID: 17603950 [TBL] [Abstract][Full Text] [Related]
14. Tigecycline: place in therapy and important considerations. Garrelts JC; Schroeder T Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574 [No Abstract] [Full Text] [Related]
15. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline. Peres E; Khaled Y; Krijanovski OI; Mineishi S; Levine JE; Kaul DR; Riddell J Transpl Infect Dis; 2009 Feb; 11(1):57-63. PubMed ID: 18983415 [TBL] [Abstract][Full Text] [Related]
16. [Experience with tigecycline in the treatment of multiresistant germs in the ICU]. Curiel Balsera E; Poullet Brea AM; Prieto Palomino MÁ Med Intensiva; 2011; 35(5):319-20. PubMed ID: 21130538 [No Abstract] [Full Text] [Related]
17. The tide of antimicrobial resistance and selection. Wilcox MH Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S6-10. PubMed ID: 19596111 [TBL] [Abstract][Full Text] [Related]
18. [Tigecycline: 10 years of history and still in full force]. Barberán J; Salso S; Alhambra A Rev Esp Quimioter; 2015 Apr; 28(2):61-78. PubMed ID: 25904513 [No Abstract] [Full Text] [Related]